葡甘露聚醣（蒟蒻／魔芋） Glucomannan / Konjac Glucomannan (KGM) × 膽固醇
結論：證據支持
葡甘露聚醣對降低總膽固醇與 LDL-C 的證據在 L11 獨立判讀屬中-高度（A 級）。
B 🟡 B 初步證據 已發布 ⚠️ medium — moderate promotional content
葡甘露聚醣對降低總膽固醇與 LDL-C 的證據在 L11 獨立判讀屬中-高度（A 級）。
核心依據：(1) 兩篇獨立高品質 meta-analysis 結論一致——Sood 2008 AJCN (14 RCT/n=531) 顯示 TC -19.28 mg/dL、LDL -15.99 mg/dL；Ho 2017 AJCN (12 RCT/n=636, PMID 28356275) 顯示 LDL -0.35 mmol/L (~10%)、non-HDL -0.32 mmol/L，效應劑量約 3-4 g/d 且 GRADE 中-高品質；(2) EFSA NDA Panel 已經正式 Article-13(1) 因果關係審議通過「Glucomannan contributes to the maintenance of normal blood cholesterol levels @ 4 g/day」，並由 Commission Regulation (EU) 432/2012 公告——這是少見正面通過 EFSA 健康宣稱的纖維補充劑；(3) NIH ODS 在 Weight Loss fact sheet 引用 Sood 2008 數據認可其降脂效果，AHA/ACC/NLA 對 viscous/soluble fiber 整類 (5-10 g/d) 一致 supportive。
降至 A 而非 S 之原因：美國學會未個別點名 glucomannan、無 Cochrane high-certainty review、亦無長期心血管終點 (MACE) 試驗；效應規模雖統計顯著但仍遜於 statin 類藥物。
⚖️
評分透明度
所有分數由 7 層證據引擎計算，過程公開可查原始分數 0.69
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
B · 已發布
信心度
78%
證據方向大致一致
證據層級
E2
多篇高品質統合分析（≥2 篇一致）
▸查看完整決策路徑（audit trail）
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.685
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
- tier_strict_requirement_check — Tier 條件達標，未降階
- detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status
Effect of glucomannan on plasma lipid and glucose concentrations, body weight, and blood pressure: systematic review and meta-analysis
結論：Glucomannan significantly lowered total cholesterol (-19.28 mg/dL), LDL-C (-15.99 mg/dL), triglycerides (-11.08 mg/dL), body weight (-0.79 kg) and fasting glucose (-7.44 mg/dL); HDL-C and BP unchanged.
前往 PubMed
Konjac glucomannan and konjac flour on lipid profile: systematic review and meta-analysis of randomized controlled trials
結論：Konjac glucomannan reduced LDL-C by 0.35 mmol/L (-16%), non-HDL-C by 0.4 mmol/L, ApoB by 0.04 g/L and total cholesterol by 0.5 mmol/L; HDL-C/TG not significantly changed.
前往 PubMed
Beneficial effects of viscous dietary fiber from Konjac-mannan in subjects with the insulin resistance syndrome: a randomized controlled metabolic trial
結論：Glucomannan fiber reduced total cholesterol by 12.4%, LDL-C by 22.0%, ApoB by 16% and B/A1 ratio by 15% vs control (all p<0.01); systolic BP lowered.
前往 PubMed
A glucomannan and chitosan fiber supplement decreases plasma cholesterol and increases cholesterol excretion in overweight normocholesterolemic humans
結論：Active group showed significant LDL-C reduction vs placebo (-32.2 mg/dL vs -3.3 mg/dL, p<0.001) and total cholesterol reduction; TG and HDL-C unchanged; combination product limits inference for glucomannan alone.
前往 PubMed
Effect of short-term ingestion of konjac glucomannan on serum cholesterol in healthy men
結論：Glucomannan reduced total cholesterol by 10% and LDL-C by 7.2% vs placebo (p<0.01); HDL-C unchanged; TG decreased modestly.
前往 PubMed
L4a US FDA
謹慎
These small cup-like products maintain their characteristics (i.e., shape, texture, firmness) and do not melt when placed in the mouth. An FDA Health Hazard Evaluation Board and physiologists with the Consumer Products Safety Commission (CPSC) assessed the products and concluded that the physical characteristics of the small cup-like candies (particularly, the packaging, shape, slipperiness, an… 來源↗
L4b EU EFSA
支持
L4c UK NHS
未表態
— 本適應症無對應資料
L4d TW TFDA / 衛福部
謹慎
市售含蒟蒻成分果凍應於個別產品外包裝顯著標示警語：1.請勿以強吸一口整粒吞食。2.五歲以下幼兒請勿食用。3.老人及兒童食用時，請大人陪伴以匙分段進食。4.請細嚼慢嚥，以免噎到。5.嬉戲時請勿食用。6.請咀嚼，勿整粒吞食（擇一標示）。適用範圍包含剖面直徑4.5公分（含）以內球形或類似球形產品，及非球形直徑3.1公分（含）以內、入口後產品表面平順滑溜之果凍。自民國95年1月1日起實施（衛署食字第0940405150號，94年9月30日公告）。 來源↗
L4e WHO
中性
The Committee concluded that the additional studies provided no evidence of adverse effects attributable to konjac flour in experimental animals. Metabolically, konjac flour behaves in the intestine in a similar way to other polysaccharide gums. ADI 'not specified' for konjac flour. 來源↗
L5a NIH Office of Dietary Supplements
謹慎
L5b Mayo Clinic
未表態
— 本適應症無對應資料
L5c Cleveland Clinic
中性
A lab study found that konjac glucomannan supplements lowered total cholesterol and "bad" cholesterol (low-density lipoprotein or LDL). However, more research is needed to see if this fiber has the same effect on people. 來源↗
L5d Harvard Health
未表態
— 本適應症無對應資料
L5e Specialty Society (condition-mapped)
未表態
Nutrition interventions that lower LDL-C levels include reducing cholesterol-raising fatty acids and dietary cholesterol, as well as increasing intakes of unsaturated fatty acids, plant proteins, viscous fibers, and reducing adiposity for patients with overweight or obesity. ... Increased consumption of foods rich in viscous, soluble fibers, such as oats, barley, and many fruits and vegetables … 來源↗
PTT · Dcard · Mobile01 彙整自公開論壇討論，非統計抽樣，僅反映社群風向。
廣告 / 業配密度 中度
低中高
📍立場總覽
台灣社群（PTT FITNESS/WomenTalk、Dcard 減肥/零食板、Mobile01）對「蒟蒻／葡甘露聚醣專為降膽固醇」幾乎查無原生實測討論。鄉民談蒟蒻幾乎都圍繞減肥、取代白飯、低熱量飽足感與蒟蒻麵／蒟蒻乾零食，膽固醇只是順帶帶過。『3克／天降壞膽固醇10%（AJCN）』的說法主要由健康媒體（康健、元氣網、Heho、ETtoday）轉述，而非社群親身回報。膽固醇題目的社群熱度集中在紅麴、魚油、納豆激酶，蒟蒻在此題訊號薄弱，且充斥『PTT／Dcard 推薦排行榜』業配清單。
💬社群實感
無共識（針對降膽固醇幾乎沒有可辨識的鄉民實測心得；社群心得集中在減肥／飽足感而非血脂）
破解迷思 社群最常見的 4 個誤解
✓
事實把蒟蒻的『減肥／飽足感』效果直接等同於『降膽固醇／降血脂』效果（兩者社群常混為一談）
✓
事實以蒟蒻麵／蒟蒻飯長期取代正餐主食就能調理三高（營養師警告恐造成營養不均與熱量過低）
✓
事實誤把廠商或部落格的『PTT、Dcard 蒟蒻推薦排行榜』當作真實鄉民共識，實多為 affiliate 業配清單
✓
事實以為市售蒟蒻＝高纖天然健康，忽略加入氫氧化鈣等凝固劑後部分纖維轉為非水溶性、且蒟蒻乾鈉含量偏高
🩹 社群通報的副作用
- 脹氣／腹瀉、稀便（纖維遇水膨脹、腸胃敏感者尤甚）
- 便秘（水分攝取不足時不減反增）
- 市售蒟蒻乾鈉含量偏高
- 口感不習慣（多人反映吃不慣、難下嚥）
- 食道／腸道阻塞風險（份量過大或未配水）
- 心臟健康飲食型態
- 生活型態調整（規律運動、健康體重、戒菸）
- 史他汀類降血脂藥物
查看 ClaimReview 結構化資料 (JSON-LD)
{
"@context": "https://schema.org",
"@type": "ClaimReview",
"url": "https://gpt-dict.com/claim/CLM-COND-cholesterol-INT-glucomannan-001/",
"datePublished": "2026-06-01",
"author": {
"@type": "Organization",
"name": "gpt-dict.com",
"url": "https://gpt-dict.com"
},
"claimReviewed": "葡甘露聚醣（蒟蒻／魔芋）能改善膽固醇",
"inLanguage": "zh-TW",
"itemReviewed": {
"@type": "Claim",
"appearance": []
},
"reviewRating": {
"@type": "Rating",
"ratingValue": 3,
"bestRating": 5,
"worstRating": 1,
"alternateName": "🟡 B 初步證據"
}
}